Q SYNTHESIS LLC
  • Quality Improvement
  • Systems Thinking
  • Implementation Science
  • Publications
  • About
  • Contact
  • Updates

Posters and Abstracts at IASLC 2023

11/30/2023

 
EP12.02-10 Personalizing Care for Patients with Advanced ALK+ NSCLC through a Blended Continuing Education and Quality Improvement Initiative
Journal of Thoracic Oncology, Volume 18, Issue 11, S678
doi.org/10.1016/j.jtho.2023.09.1303 

EP07.04-22 Current Biomarker Testing Practices for Early Stage Non-small Cell Lung Cancer (NSCLC) In Community and Academic Centers in the US
Journal of Thoracic Oncology, Volume 18, Issue 11, S554
doi.org/10.1016/j.jtho.2023.09.1035 
​
EP07.04 EARLY-STAGE NON-SMALL CELL LUNG CANCER - PROGRESS IN PATHOLOGY| VOLUME 18, ISSUE 11, SUPPLEMENT , S554, NOVEMBER 2023

EP12.02 METASTATIC NON-SMALL CELL LUNG CANCER – TARGETED THERAPY - FUSIONS| VOLUME 18, ISSUE 11, SUPPLEMENT , S678, NOVEMBER 2023


Comments are closed.

    Author

    @DrJosephKim
    Joseph Kim, MD, MPH, MBA, FACEHP is the Founder and President of Q Synthesis LLC.

    ​View Dr. Kim's bio on LinkedIn. 

    ​


    Sign up to receive updates:
Q Synthesis LLC
Home

About

Contact
​

​Publications
Picture
​Quality Improvement 
​
Systems Thinking 

​Implementation Science 

​Updates
www.qsynthesis.com
  • Quality Improvement
  • Systems Thinking
  • Implementation Science
  • Publications
  • About
  • Contact
  • Updates